Cargando…
Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts. This recently FDA-cleared system consists of the insulin pump...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313290/ https://www.ncbi.nlm.nih.gov/pubmed/30239214 http://dx.doi.org/10.1177/1932296818798836 |
_version_ | 1783383899543437312 |
---|---|
author | Ly, Trang T. Layne, Jennifer E. Huyett, Lauren M. Nazzaro, David O’Connor, Jason B. |
author_facet | Ly, Trang T. Layne, Jennifer E. Huyett, Lauren M. Nazzaro, David O’Connor, Jason B. |
author_sort | Ly, Trang T. |
collection | PubMed |
description | The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts. This recently FDA-cleared system consists of the insulin pump (“Pod”), which is worn on body and delivers insulin, and the Personal Diabetes Manager (PDM), which is a handheld device used to wirelessly control and monitor the Pod functionality. The PDM can also be paired with the CONTOUR(®) NEXT ONE blood glucose (BG) meter (Ascensia Diabetes Care, Basel, Switzerland) to wirelessly receive BG readings. This review provides a detailed description of the Pod and PDM. Key features of the Pod are described, including the novel pump delivery mechanism, waterproof (IP28) housing design, and automated cannula insertion. The technology introduced in the new system, such as touchscreen PDM interface, Bluetooth(®) wireless technology, and wireless internet connectivity, is also presented. Last, Omnipod(®) Insulin Management System clinical data are reviewed, including early feasibility results for the Omnipod Horizon™ Automated Glucose Control hybrid closed-loop system. |
format | Online Article Text |
id | pubmed-6313290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-63132902019-09-21 Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age Ly, Trang T. Layne, Jennifer E. Huyett, Lauren M. Nazzaro, David O’Connor, Jason B. J Diabetes Sci Technol Special Section: Insulin Patch Pumps and Novel Insulin Delivery Systems The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts. This recently FDA-cleared system consists of the insulin pump (“Pod”), which is worn on body and delivers insulin, and the Personal Diabetes Manager (PDM), which is a handheld device used to wirelessly control and monitor the Pod functionality. The PDM can also be paired with the CONTOUR(®) NEXT ONE blood glucose (BG) meter (Ascensia Diabetes Care, Basel, Switzerland) to wirelessly receive BG readings. This review provides a detailed description of the Pod and PDM. Key features of the Pod are described, including the novel pump delivery mechanism, waterproof (IP28) housing design, and automated cannula insertion. The technology introduced in the new system, such as touchscreen PDM interface, Bluetooth(®) wireless technology, and wireless internet connectivity, is also presented. Last, Omnipod(®) Insulin Management System clinical data are reviewed, including early feasibility results for the Omnipod Horizon™ Automated Glucose Control hybrid closed-loop system. SAGE Publications 2018-09-21 /pmc/articles/PMC6313290/ /pubmed/30239214 http://dx.doi.org/10.1177/1932296818798836 Text en © 2018 Diabetes Technology Society http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Special Section: Insulin Patch Pumps and Novel Insulin Delivery Systems Ly, Trang T. Layne, Jennifer E. Huyett, Lauren M. Nazzaro, David O’Connor, Jason B. Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age |
title | Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age |
title_full | Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age |
title_fullStr | Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age |
title_full_unstemmed | Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age |
title_short | Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age |
title_sort | novel bluetooth-enabled tubeless insulin pump: innovating pump therapy for patients in the digital age |
topic | Special Section: Insulin Patch Pumps and Novel Insulin Delivery Systems |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313290/ https://www.ncbi.nlm.nih.gov/pubmed/30239214 http://dx.doi.org/10.1177/1932296818798836 |
work_keys_str_mv | AT lytrangt novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage AT laynejennifere novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage AT huyettlaurenm novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage AT nazzarodavid novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage AT oconnorjasonb novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage |